1. Home
  2. EVH vs IOVA Comparison

EVH vs IOVA Comparison

Compare EVH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolent Health Inc

EVH

Evolent Health Inc

HOLD

Current Price

$2.96

Market Cap

344.8M

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.93

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVH
IOVA
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.8M
2.1B
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
EVH
IOVA
Price
$2.96
$3.93
Analyst Decision
Strong Buy
Buy
Analyst Count
15
10
Target Price
$7.93
$9.11
AVG Volume (30 Days)
3.1M
16.9M
Earning Date
05-20-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$907,957,000.00
N/A
Revenue This Year
$33.03
$49.14
Revenue Next Year
$16.03
$51.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$1.64
52 Week High
$11.92
$5.63

Technical Indicators

Market Signals
Indicator
EVH
IOVA
Relative Strength Index (RSI) 43.92 52.57
Support Level $2.53 $1.99
Resistance Level $4.20 $4.34
Average True Range (ATR) 0.28 0.50
MACD 0.00 -0.00
Stochastic Oscillator 38.08 28.72

Price Performance

Historical Comparison
EVH
IOVA

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: